HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ekkehard Brockstedt Selected Research

BI 695501

10/2021Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ekkehard Brockstedt Research Topics

Disease

1Abscess
10/2021
1Rheumatoid Arthritis
10/2021
1Crohn Disease (Crohn's Disease)
10/2021
1Erythema
10/2021
1Exanthema (Rash)
10/2021
1Hypersensitivity (Allergy)
10/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
10/2021
1Sinusitis
10/2021
1Surgical Wound Infection
10/2021
1Pulmonary Tuberculosis
10/2021
1Psoas Abscess
10/2021

Drug/Important Bio-Agent (IBA)

1BI 695501IBA
10/2021
1Adalimumab (Humira)FDA Link
10/2021
1Infliximab (Remicade)FDA Link
10/2021
1Biosimilar PharmaceuticalsIBA
10/2021